PLA2G16 抗体 (AA 1-132) (FITC)
-
- 抗原 See all PLA2G16 抗体
- PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
-
抗原表位
- AA 1-132
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This PLA2G16 antibody is conjugated to FITC
- 应用范围
- 请咨询
- 交叉反应
- 人
- 纯化方法
- >95%, Protein G purified
- 免疫原
- Recombinant Human HRAS-like suppressor 3 protein (1-132AA)
- 亚型
- IgG
- Top Product
- Discover our top product PLA2G16 Primary Antibody
-
anti-HRAS-Like Suppressor 3 (PLA2G16) (AA 1-162) antibody
PLA2G16 适用: 人 WB, IF, IP 宿主: 兔 Polyclonal unconjugated
anti-HRAS-Like Suppressor 3 (PLA2G16) (AA 1-162) antibodyPLA2G16 适用: 人 WB, IF 宿主: 小鼠 Polyclonal unconjugated
anti-HRAS-Like Suppressor 3 (PLA2G16) (AA 1-162) antibodyPLA2G16 适用: 人 ELISA, WB 宿主: 小鼠 Monoclonal 4C4-2A11 unconjugated
anti-HRAS-Like Suppressor 3 (PLA2G16) (AA 1-132) antibodyPLA2G16 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-HRAS-Like Suppressor 3 (PLA2G16) antibodyPLA2G16 适用: 人, 小鼠, 大鼠 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-HRAS-Like Suppressor 3 (PLA2G16) (AA 68-162) antibodyPLA2G16 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-HRAS-Like Suppressor 3 (PLA2G16) (AA 104-132), (C-Term) antibodyPLA2G16 适用: 人, 小鼠 WB, FACS 宿主: 兔 Polyclonal RB15054 unconjugated
-
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- 抗原
- PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
- 别名
- PLA2G16 (PLA2G16 产品)
- 别名
- HRASLS3 antibody, HREV107 antibody, HRSL3 antibody, AdPLA antibody, H-REV107-1 antibody, HREV107-1 antibody, HREV107-3 antibody, C78643 antibody, Hrasls3 antibody, Hrev107 antibody, MLP-3 antibody, phospholipase A2 group XVI antibody, phospholipase A2, group XVI antibody, PLA2G16 antibody, Pla2g16 antibody
- 背景
-
Background: Exhibits PLA1/2 activity, catalyzing the calcium-independent hydrolysis of acyl groups in various phosphatidylcholines (PC) and phosphatidylethanolamine (PE). For most substrates, PLA1 activity is much higher than PLA2 activity. Specifically catalyzes the release of fatty acids from phospholipids in adipose tissue (By similarity). N- and O-acylation activity is hardly detectable. Might decrease protein phosphatase 2A (PP2A) activity.
Aliases: Adipose specific phospholipase A2 antibody, Adipose specific PLA2 antibody, Adipose-specific phospholipase A2 antibody, AdPLA antibody, Ca independent phospholipase A1/2 antibody, Group XVI phospholipase A1/A2 antibody, Group XVI phospholipase A2 antibody, H rev 107 protein homolog antibody, H REV107 1 antibody, H-rev 107 protein homolog antibody, HRAS like suppressor 1 antibody, HRAS like suppressor 3 antibody, HRAS-like suppressor 1 antibody, HRAS-like suppressor 3 antibody, HREV107 1 antibody, HREV107 3 antibody, HREV107 antibody, HREV107-1 antibody, HREV107-3 antibody, HRSL3 antibody, HRSL3_HUMAN antibody, Phospholipase A2 group XVI antibody, Pla2g16 antibody, Renal carcinoma antigen NY REN 65 antibody, Renal carcinoma antigen NY-REN-65 antibody
- UniProt
- P53816
- 途径
- Inositol Metabolic Process
-
